Dupilumab and Atopic Dermatitis Flares: An Observational Study to Identify Common Clinical Features in Patients Who Have Exacerbations despite Biological Therapy
Filomena Russo(University of Siena), Francesco Santi(University of Siena), Laura Lazzeri(University of Siena), Alessandra Cartocci(University of Siena), Angelo Massimiliano D’Erme(University of Florence), Vittoria Cioppa(University of Siena), Pietro Rubegni(University of Siena), Nicola Milanesi(Ospedale del Ceppo)
Cited by 3
Related Papers
The Spectrum of Spitz Nevi
|Archives of Dermatology|2005|173
Potential Infectious Etiology of Behçet's Disease
|Pathology Research International|2011|75
Moderate‐to‐severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real‐world experience
|Journal of the European Academy of Dermatology and Venereology|2022|60
Position statement of the <scp>EADV</scp> Artificial Intelligence (<scp>AI</scp>) Task Force on <scp>AI</scp>‐assisted smartphone apps and web‐based services for skin disease
|Journal of the European Academy of Dermatology and Venereology|2023|52
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study
|Expert Opinion on Biological Therapy|2020|43